FDA In Brief > FDA In Brief: FDA advances enforcement policy for certain marketed tobacco products that receive a not substantially equivalent order

FDA In Brief > FDA In Brief: FDA advances enforcement policy for certain marketed tobacco products that receive a not substantially equivalent order





FDA In Brief: FDA advances enforcement policy for certain marketed tobacco products that receive a not substantially equivalent order



Today, the U.S. Food and Drug Administration issued a draft guidance, “Enforcement Policy for Certain Marketed Tobacco Products,” which, when final, will explain the agency’s current thinking regarding its enforcement policy for manufacturers, importers and distributors of certain marketed tobacco products that receive a not substantially equivalent (NSE) order and will explain the sell-off time allowed, as well as the enforcement policy for retailers with such products in their inventory. These certain marketed tobacco products include “provisional” tobacco products (those that were first introduced or delivered for...